 |
Appello Pharmaceuticals
Last updated: April 15, 2024
President and COO Brian Laden
Country: USA | Funding: $29M (+)
Website: https://appellopharma.com/
Appello Pharmaceuticals is focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.
Website: https://appellopharma.com/
Appello Pharmaceuticals is focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.